![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/02/2891851/0/en/ALX-Oncology-Presents-First-Evorpacept-Combination-Data-with-an-Antibody-Drug-Conjugate-from-Phase-1-ASPEN-07-Clinical-Trial-in-Patients-with-Advanced-Bladder-Cancer.html
https://www.globenewswire.com/news-release/2024/05/29/2889922/0/en/ALX-Oncology-Announces-Participation-in-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/09/2879111/0/en/ALX-Oncology-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/07/2876800/0/en/ALX-Oncology-Appoints-Allison-Dillon-as-Chief-Business-Officer.html
https://www.globenewswire.com/news-release/2024/04/30/2872344/0/en/ALX-Oncology-Announces-Initiation-of-Phase-2-Investigator-Sponsored-Trial-of-Neoadjuvant-Radiation-and-Evorpacept-in-Combination-with-Pembrolizumab-in-Patients-with-Untreated-HPV-M.html
https://www.globenewswire.com/news-release/2024/04/24/2868753/0/en/ALX-Oncology-Announces-Two-Evorpacept-Abstracts-Accepted-for-Poster-Presentation-at-2024-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/09/2860415/0/en/ALX-Oncology-Reports-Encouraging-Clinical-Data-of-Evorpacept-in-Combination-with-Standard-of-Care-in-an-Ongoing-Phase-1-2-Clinical-Trial-in-Patients-with-Relapsed-or-Refractory-B-c.html
https://finance.yahoo.com/news/alx-oncology-elevated-valuation-analyst-204806187.html
https://www.globenewswire.com//news-release/2024/03/07/2842727/0/en/ALX-Oncology-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/05/2840941/0/en/ALX-Oncology-Announces-Two-Evorpacept-Clinical-Abstracts-Accepted-for-Presentation-at-the-AACR-Annual-Meeting.html